Arcellx, Inc.
(NASDAQ: ACLX)
Arcellx, Inc is a clinical-stage biotechnology company, which provides cell therapy through the development of innovative immunotherapies for patients with cancer and other incurable diseases. The company was founded by David M. Hilbert and Luba Zaritskaya in December 2014 and is headquartered in Redwood City MD.
68.450
-4.490
(-6.16%)
Range
66.000 - 75.030
(13.68%)
Open
72.200
Previous Close
72.940
Bid Price
42.810
Bid Volume
8
Ask Price
44.950
Ask Volume
11
Volume
2,123,743
Value
-
Remark
Delayed prices. Updated at 05 Dec 2025 05:00.
Data powered by
View All Events
Loading Chart...
Please login to view stock data and analysis
